1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Alex's Lemonade Stand Foundation 'A' Award (Pediatric Cancer Research 2026) is sponsored by Alex's Lemonade Stand Foundation (ALSF). The 'A' Award supports early-career investigators launching careers in pediatric cancer research, specifically clinicians and scientists within their first five years of independent research who wish to establish a focused pediatric oncology research program.
ALSF takes a high-risk, high-reward approach to grant selection.
Get alerted about grants like this
Get emailed when new opportunities from “Alex's Lemonade Stand Foundation (ALSF)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Early-career investigators (clinicians and scientists) within their first five years of independent research who wish to establish a focused pediatric oncology research program. Confirm the full requirements in the official notice before applying.
The current listing shows $100,000 over two years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was June 1, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Alex's Lemonade Stand Foundation 'A' Award (Pediatric Cancer Research 2026) is funded by Alex's Lemonade Stand Foundation (ALSF). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward interdisciplinary projects that leverage AI, machine learning, and advanced data science to address pressing questions in biomedical and public health research. It seeks to advance fundamental scientific and engineering contributions across disciplines to solve key health problems.
NSF published solicitation 26-508 establishing TechAccess: AI-Ready America, a three-round program to fund up to 56 statewide AI coordination hubs — one per state, the District of Columbia, and each U.S. territory — at $1M per year for three years with a possible fourth-year extension. Round one funds 10 hubs with letters of intent due June 16, 2026 and full proposals due July 16. Round two opens December 15 for an additional 20 hubs; round three covers the remainder in 2027. The program is NSF's largest single bet on AI literacy and statewide AI capacity outside of the existing AI Research Institutes. Here is the eligibility math, the convening-authority gate, the partnership architecture that wins, and the strategic question every state higher-ed system needs to answer in the next two weeks.
Read articleUniversities and advocacy groups have won 33 of 64 key cases challenging federal grant policies. The government dropped appeals on indirect cost caps and DEI rules. A comprehensive scorecard of the legal battles that will determine research funding for years.
Read article